Inactive

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Agena Bioscience for the purchase of an iPLEX® Gold, PCR Reagent and SpectroCHIP® Kit -... The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Agena Bioscience for the purchase of an iPLEX® Gold, PCR Reagent and SpectroCHIP® Kit - CPM (10x384) and MassARRAY® Clean Resin, The National Center for Birth Defects and Developmental Disabilities, Division of Blood Disorders has a need for the purchase of laboratory supplies for already existing laboratory equipment. These are reagents for a multiplex genotyping project on the Agena MassArray MALDI-TOF mass spectrometer system in the laboratory. The equipment and the reagents designed for it are proprietary, specific, and sold only by Agena. There are no other companies that sell reagents that are compatible with this laboratory equipment. The Agena MassArray MALDI-TOF mass spectrometer system is being used for ongoing Division of Blood Disorders projects to continue the genotyping projects currently ongoing in the laboratory. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) calendar days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Contract Specialist at PYX9@cdc.gov by 11:00AM ET on July 23, 2021.